Lataa...
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
Although immunotherapy is a potential strategy to resist cancers, due to the inadequate acknowledge, this treatment is not always effective for diffuse large B cell lymphoma (DLBCL) patients. Based on the current situation, it is critical to systematically investigate the immune pattern. According t...
Tallennettuna:
| Julkaisussa: | Front Genet |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902938/ https://ncbi.nlm.nih.gov/pubmed/33643388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.625414 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|